Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma

Carcinogenesis

Volumn 28, Issue 4, 2007, Pages 823-827

  Lan, Qing ^a   Zheng, Tongzhang ^b   Chanock, Stephen ^a   Zhang, Yawei ^b   Shen, Min ^a   Wang, Sophia S ^a   Berndt, Sonja I ^a   Zahm, Shelia H ^a   Holford, Theodore R ^b   Leaderer, Brian ^b   Yeager, Meredith ^a   Welch, Robert ^a   Hosgood, Dean ^a   Boyle, Peter ^c   Rothman, Nathaniel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER RISK; CASE CONTROL STUDY; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLICULAR LYMPHOMA; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VARIATION (GENETICS);

EID: 34047141698     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl196     Document Type: Article

References (27)

1. Creagh,E.M., Conroy,H. and Martin,S.J. (2003) Caspase-activation pathways in apoptosis and immunity. Immunol. Rev., 193, 10-21.
2. Dales,J.P., Plumas,J., Palmerini,F., Devilard,E., Defrance,T., Lajmanovich,A., Pradel,V., Birg,F. and Xerri,L. (2001) Correlation between apoptosis microarray gene expression profiling and histopathological lymph node lesions. Mol. Pathol., 54, 17-23.
3. Alizadeh,A.A., Eisen,M.B., Davis,R.E. et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
4. Shin,M.S., Kim,H.S., Kang,C.S. et al. (2002) Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood, 99, 4094-4099.
5. Soung,Y.H., Lee,J.W., Kim,S.Y., Park,W.S., Nam,S.W., Lee,J.Y., Yoo,N.J. and Lee,S.H. (2004) Somatic mutations of CASP3 gene in human cancers. Hum. Genet., 115, 112-115.
6. Mandruzzato,S., Brasseur,F., Andry,G., Boon,T. and van der,B.P. (1997) A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med., 186, 785-793.
7. Abel,F., Sjoberg,R.M., Ejeskar,K., Krona,C. and Martinsson,T. (2002) Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours. Br. J. Cancer, 86, 596-604.
8. Woo,M., Hakem,R., Furlonger,C. et al. (2003) Caspase-3 regulates cell cycle in B cells: A consequence of substrate specificity. Nat. Immunol., 4, 1016-1022.
9. Frank,B., Bermejo,J.L., Hemminki,K., Klaes,R., Bugert,P., Wappenschmidt,B., Schmutzler,R.K. and Burwinkel,B. (2005) Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl Cancer Inst., 97, 1012-1013.
10. Frank,B., Hemminki,K., Wappenschmidt,B., Meindl,A., Klaes,R., Schmutzler,R.K., Bugert,P., Untch,M., Bartram,C.R. and Burwinkel,B. (2006) Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis, 27, 606-609.
11. Heck,A.L., Bray,M.S., Scott,A., Blanton,S.H. and Hecht,J.T. (2005) Variation in CASP10 gene is associated with idiopathic talipes equinovarus. J. Pediatr. Orthop., 25, 598-602.
12. MacPherson,G., Healey,C.S., Teare,M.D., Balasubramanian,S.P., Reed,M.W., Pharoah,P.D., Ponder,B.A., Meuth,M., Bhattacharyya,N.P. and Cox,A. (2004) Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl Cancer Inst., 96, 1866-1869.
13. Kuersten,S. and Goodwin,E.B. (2003) The power of the 3′ UTR: translational control and development. Nat. Rev. Genet., 4, 626-637.
14. Morton,L.M., Holford,T.R., Leaderer,B. et al. (2003) Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control, 14, 687-694.
15. Zhang,Y., Holford,T.R., Leaderer,B., Boyle,P., Zahm,S.H., Flynn,S., Tallini,G., Owens,P.H. and Zheng,T. (2004) Hair-coloring product use and risk of non-Hodgkin's lymphoma: A population-based case-control study in Connecticut. Am. J. Epidemiol., 159, 148-154.
16. Lan,Q., Zheng,T., Rothman,N. et al. (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood, 107, 4101-4108.
17. Packer,B.R., Yeager,M., Burdett,L. et al. (2006) SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res., 34, D617-D621.
18. Barrett,J.C., Fry,B., Maller,J., Daly, M.J. (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
19. Excoffier,L. and Slatkin,M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
20. Kuida,K., Haydar,T.F., Kuan,C.Y., Gu,Y., Taya,C., Karasuyama,H., Su,M.S., Rakic,P. and Flavell,R.A. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell, 94, 325-337.
21. Chun,H.J., Zheng,L., Ahmad,M. et al. (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature, 419, 395-399.
22. Wang,J., Zheng,L., Lobito,A., Chan,F.K., Dale,J., Sneller,M., Yao,X., Puck,J.M., Straus,S.E. and Lenardo,M.J. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell, 98, 47-58.
23. Boatright,K.M. and Salvesen,G.S. (2003) Caspase activation. Biochem. Soc. Symp. pp. 233-242.
24. Nagata,S. (1999) Biddable death. Nat. Cell Biol., 1, E143-E145.
25. Budihardjo,I., Oliver,H., Lutter,M., Luo,X. and Wang,X. (1999) Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol., 15, 269-290.
26. Bhatti,P., Sigurdson,A.J., Wang,S.S., Chen,J., Rothman,N., Hartge,P., Bergen,A.W. and Landi,M.T. (2005) Genetic variation and willingness to participate in epidemiologic research: Data from three studies. Cancer Epidemiol. Biomarkers Prev., 14, 2449-2453.
27. Wacholder,S., Chanock,S., Garcia-Closas,M., El Ghormli,L. and Rothman,N. (2004) Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J. Natl Cancer Inst, 96, 434-442.